Document nN5oRodZw1GDRDGxB2VRXYdBm

Monsanto '. ro .name . loc*t.on, Cumming Paton - General Offices D*Tl *u"JtCT Htrt-tNCi TO : March 23, 1970 . AROCLOR 1260/5442 . J. E. Smith JSMIT cc M. W. Farrar - JFQ Research --^ W. E. Maledon - WHALE ' W. B. Papageorge - WPAPA W. E. Schalk/j. E. Sprlnggate W. F. Waychoff - jrvy 2^ S In their understandable rush to get Aroclor 1254/1260 replacements, I think Functional Fluids may forget I occasionally that Plasticizers exist. As you know, we were told about the termination of Aroclor 1260 at Anniston only after the decision was made. I ' understand the decision to move all Aroclor 1260 to WGK was made to free up a tank for a new Pydraul blend containing Aroclor 5442. Our 1970 forecast on Aroclor 1260 is as follows: ; Anniston WGK Aroclor 1260 100 M Lb. 200 MLb. Aroclor 1260 (10$ Tol.) 375 M.Lb. 0 I don't see any major problem with Aroclor 1260 per se provided I get two-three weeks lead time to notify cus tomers. Please don't ship remaining Aroclor 1260 at " Anniston to WGK till this is done. We may have a customer problem concerning Aroclor 1260 (10^ Toluene). We have one customer who buys 180 M pounds/year. The switch will increase his freight costS| The switch by Functional Fluids to Aroclor 5442 will put1 greater demands on an already tight terphenyl situation. X^*. L. _ Can we be assured that HB-4o/Aroclor 5460 plasticizer sales will be protected. I guess Ed Maledon will keep A.an eye out for lower plasticizer bSsts Decause Functional Fluids will now stiarersfcart-up)ahd~ c\sts of the new solid's / 'g I O+i plant". .......... " -V ------- *7Vr 0 Finally, the greater use of ~t'erp7Tenyr derivatives as /ii* 4 / Aroclor 1254/1260 replacements could t ring_ a sell-out situation on the new solid plant' closer than 1974. I DSW 201417 W*- STLCOPCB4059482 remember seeing a report come from Anniston during our search for a low color Aroclor 5460 process in which it was sated'''that~'PtAlCl0 catalyst allowed faster chlorin ation than FeCl~ This has been demonstrated in the' laboratory. Perhaps it~~should be studied as a means of cost reduction and de-bottlenecking. Perhaps Martin Farrar could comment on this. I would like this potential catalyst to be mentioned in our FDA petition on Aroclor 5460 to avoid later problems. If it could not be used with Aroclor 5460 for FDA reasons, perhaps it could be used with Aroclor 1268/5060/5442 to allow better pro duction schedules. " 21 ^ ft f A d> , uXi-t, , J&L (7 7* '^ `* Uh /dbw Cumming Paton dS\N 201418 STLCOPCB4059483